oxonic acid has been researched along with Epistaxis in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events were assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events." | 1.37 | Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study. ( Asaka, M; Hatanaka, K; Hosokawa, A; Iwanaga, I; Kato, T; Komatsu, Y; Kusumi, T; Miyagishima, T; Nakamura, M; Sakata, Y; Sogabe, S; Yuki, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasumatsu, R | 1 |
| Nakashima, T | 1 |
| Sato, M | 1 |
| Nakano, T | 1 |
| Kogo, R | 1 |
| Hashimoto, K | 1 |
| Sawatsubashi, M | 1 |
| Nakagawa, T | 1 |
| Sogabe, S | 1 |
| Komatsu, Y | 1 |
| Yuki, S | 1 |
| Kusumi, T | 1 |
| Hatanaka, K | 1 |
| Nakamura, M | 1 |
| Kato, T | 1 |
| Miyagishima, T | 1 |
| Hosokawa, A | 1 |
| Iwanaga, I | 1 |
| Sakata, Y | 1 |
| Asaka, M | 1 |
2 other studies available for oxonic acid and Epistaxis
| Article | Year |
|---|---|
Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemor | 2017 |
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2011 |